- Underlying pre-tax profits at Animalcare - a leading supplier of veterinary medicines - rose by 21% to £3.0m in the year to the end of June.

Revenue from continuing operations rose 5.4% to £11.8m while underlying operating profit was up 17.3% at £3.05m.

The final dividend of 3p takes the total for the year to 4p (2010: 3p).

Chairman James Lambert said: "During the past financial year and now in the current one, there has been little or no growth in the veterinary medicines market in the UK.

"However, with the launch of several new veterinary drugs in the first quarter building on those introduced during the last financial year, and with the reintroduction of Buprecare, your board believes that we will continue to grow the business markedly faster than the market overall and increase our market share."

He said trading in the year to date has started in line with the board's expectations.

At 8:04am: [LON:ANCR] share price was 0p at 167.5p

Story provided by